Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
Hypertrophic cardiomyopathy (HCM) is a dominant genetic disorder of the myocardium associated with dysfunctional contractile proteins. The major risk of HCM is sudden cardiac death, which may occur even in asymptomatic carriers. Causes are highly heterogeneous. Over 140 different mutations in nine s...
Na minha lista:
| Udgivet i: | Curr Control Trials Cardiovasc Med |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2000
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59597/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714407/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-1-041 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|